Inspiral 20 SR is a generic sustained-release formulation of methylphenidate 20mg, widely used to treat attention-related disorders such as ADHD and narcolepsy. It is designed to provide prolonged symptom control throughout the day with a single morning dose, reducing the need for multiple administrations and supporting better compliance, especially in school and work settings.

- Sleep & Mental Health > ADHD Inspiral 20 SR is primarily prescribed for ADHD (Attention Deficit Hyperactivity Disorder), helping individuals enhance focus, reduce impulsivity, and manage hyperactivity. Its extended duration makes it especially effective for maintaining cognitive and behavioral stability during daytime hours. > Improve memory, concentration and brain function While not officially approved for cognitive enhancement, methylphenidate is sometimes used off-label to improve short-term memory and mental alertness. This includes interest among students and professionals for increased academic or task-related performance, though such usage is not medically recommended for individuals without ADHD. > Autism In some children with autism spectrum disorder (ASD), methylphenidate is used adjunctively to manage hyperactivity and attention issues. It is considered helpful in improving behavior regulation, particularly when standard behavioral interventions are insufficient.

Methylphenidate acts as a central nervous system stimulant by inhibiting the reuptake of dopamine and norepinephrine. This increases their concentration in the synaptic cleft, promoting better attention, emotional regulation, and executive function. It mimics the effect of naturally occurring catecholamines, enhancing activity in brain regions involved in focus and impulse control.

Adults – ADHD & Narcolepsy Immediate-Release (IR): - Usual dose: 20–30 mg/day, divided 2–3 times daily before meals - Maximum: 60 mg/day - Titrate gradually based on response and tolerability Extended-Release (ER): - Once-daily use based on prior IR response - Do not switch products mg-for-mg due to variable pharmacokinetics - Titration: weekly in fixed increments - Maximum: 72–100 mg/day depending on formulation - Evening formulations may be used to sustain next-morning effects Pediatrics (6+ years) – ADHD & Narcolepsy Immediate-Release (IR): - Start: 5 mg twice daily before meals - Titrate: Increase by 5–10 mg/week - Maximum: 60 mg/day Extended-Release (ER): - Preferred for school-aged children - Starting dose depends on age/weight and IR exposure - Max dose: - 6–12 years: up to 54 mg/day - 13+ years: up to 72 mg/day or 2 mg/kg/day (whichever is lower) - Non-swallowable formats like patches and ODTs available General Clinical Considerations - Weekly titration is standard - Therapy should be individualized based on tolerability, response, and lifestyle - Discontinue if no improvement after 1 month - Monitor for appetite loss, insomnia, irritability - Take consistently with or without food - Avoid direct switching between ER products due to different release patterns

Store in a tightly closed container at 20–25°C (68–77°F), away from moisture, heat, and direct sunlight. Keep out of reach of children and avoid bathroom storage to prevent humidity exposure.

Common side effects include: - Insomnia - Loss of appetite - Weight loss - Increased heart rate or blood pressure - Irritability or nervousness - Abdominal pain or nausea Serious adverse reactions (rare): - Cardiac arrhythmias - Psychiatric events (mania, psychosis) - Growth suppression in children - Dependency or misuse in long-term use Regular follow-up is recommended to monitor cardiovascular status and growth in pediatric patients.